Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

Patients with cervical cancer demonstrated better sexual health and quality of life after undergoing simple hysterectomies ...

Ultimately, the research is still limited on CBD for neuropathy. More studies are needed before experts can conclude CBD is an effective treatment ... will depend on the type you buy.

At Regenerative Neuropathy, highly trained doctors are using a cutting-edge treatment and successfully slowing and often reversing the disease without addictive medications. The next 15 callers ...

NEW RESEARCH presented at EASD 2024 revealed that maternal Type 1 diabetes (T1D) provides long-term relative protection ...

In today’s 2024 modern era, many people are experiencing constant foot discomfort and pain. Whether it is because of ...

In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Analysis Marks the First Study of Spinal Cord Stimulation to Demonstrate Long-term, Significant, and Clinically Meaningful Reductions in HbA1c and Weight in Study Participants with Painful Diabetic ...